<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8</volume><submitter>Bardanzellu F</submitter><pubmed_abstract>&lt;b>Introduction:&lt;/b> In premature neonates, the persistence of hemodynamically significant ductus arteriosus (hsPDA) can be associated with short- and long-term consequences, impairing their outcome. The correct strategy of management for such condition is under debate, especially regarding contraindications and/or side effects. In recent years, metabolomics was applied to several perinatal, pediatric, and adult conditions to investigate potential biomarkers of disease, which have become useful for early diagnosis and/or therapeutic management. &lt;b>Aim of the Study:&lt;/b> The main purpose of our exploratory study was to asses, through &lt;sup>1&lt;/sup>H-NMR metabolomics analysis of urinary samples at birth, possible metabolic pathways differentiating, with a significant predictive power, those pre</pubmed_abstract><journal>Frontiers in pediatrics</journal><pagination>613749</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7779766</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data.</pubmed_title><pmcid>PMC7779766</pmcid><pubmed_authors>Atzei A</pubmed_authors><pubmed_authors>Fanos V</pubmed_authors><pubmed_authors>Bardanzellu F</pubmed_authors><pubmed_authors>Neroni P</pubmed_authors><pubmed_authors>Piras C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data.</name><description>&lt;b>Introduction:&lt;/b> In premature neonates, the persistence of hemodynamically significant ductus arteriosus (hsPDA) can be associated with short- and long-term consequences, impairing their outcome. The correct strategy of management for such condition is under debate, especially regarding contraindications and/or side effects. In recent years, metabolomics was applied to several perinatal, pediatric, and adult conditions to investigate potential biomarkers of disease, which have become useful for early diagnosis and/or therapeutic management. &lt;b>Aim of the Study:&lt;/b> The main purpose of our exploratory study was to asses, through &lt;sup>1&lt;/sup>H-NMR metabolomics analysis of urinary samples at birth, possible metabolic pathways differentiating, with a significant predictive power, those pre</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2026-07-09T10:58:48.099Z</modification><creation>2026-07-09T10:35:05.151Z</creation></dates><accession>S-EPMC7779766</accession><cross_references><pubmed>33409262</pubmed><doi>10.3389/fped.2020.613749</doi></cross_references></HashMap>